These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 6347034)
1. Oral physostigmine and lecithin improve memory in Alzheimer disease. Thal LJ; Fuld PA; Masur DM; Sharpless NS Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034 [TBL] [Abstract][Full Text] [Related]
2. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease. Wettstein A Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183 [TBL] [Abstract][Full Text] [Related]
3. Effects of physostigmine and lecithin on memory in Alzheimer disease. Peters BH; Levin HS Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419 [TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease. Thal LJ; Masur DM; Sharpless NS; Fuld PA; Davies P Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):627-36. PubMed ID: 3797688 [TBL] [Abstract][Full Text] [Related]
5. Improved verbal learning after outpatient oral physostigmine therapy in patients with dementia of the Alzheimer type. Sevush S; Guterman A; Villalon AV J Clin Psychiatry; 1991 Jul; 52(7):300-3. PubMed ID: 2071560 [TBL] [Abstract][Full Text] [Related]
7. Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease. Levin HS; Peters BH Ann Neurol; 1984 Feb; 15(2):210. PubMed ID: 6703661 [No Abstract] [Full Text] [Related]
8. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial. Jenike MA; Albert MS; Heller H; Gunther J; Goff D J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997 [TBL] [Abstract][Full Text] [Related]
9. Memory enhancement with oral physostigmine in Alzheimer's disease. N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388 [No Abstract] [Full Text] [Related]
10. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Volger BW Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522 [TBL] [Abstract][Full Text] [Related]
11. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Levin HS; Peters BH; Kalisky Z; High WM; von Laufen A; Eisenberg HM; Morrison DP; Gary HE Cent Nerv Syst Trauma; 1986; 3(4):333-42. PubMed ID: 3555852 [TBL] [Abstract][Full Text] [Related]
12. Drug combination may improve memory. Geriatrics; 1979 Oct; 34(10):15. PubMed ID: 478303 [No Abstract] [Full Text] [Related]
13. Effects of oral physostigmine in Alzheimer's disease. Stern Y; Sano M; Mayeux R Ann Neurol; 1987 Sep; 22(3):306-10. PubMed ID: 3674795 [TBL] [Abstract][Full Text] [Related]
14. Memory decline in the aged: treatment with lecithin and physostigmine. Drachman DA; Glosser G; Fleming P; Longenecker G Neurology; 1982 Sep; 32(9):944-50. PubMed ID: 6287359 [TBL] [Abstract][Full Text] [Related]